{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:40:17Z","timestamp":1793932817420,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Federaci\u00f3n de Ataxias de Espa\u00f1a","award":["CONVOCATORIA DE AYUDAS A LA INVESTIGACI\u00d3N"],"award-info":[{"award-number":["CONVOCATORIA DE AYUDAS A LA INVESTIGACI\u00d3N"]}]},{"name":"Federaci\u00f3n de Ataxias de Espa\u00f1a","award":["CONVOCATORIA DE AYUDAS A LA INVESTIGACI\u00d3N"],"award-info":[{"award-number":["CONVOCATORIA DE AYUDAS A LA INVESTIGACI\u00d3N"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI19\/01084"],"award-info":[{"award-number":["PI19\/01084"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50975-4","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:33:25Z","timestamp":1778654005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validation of circulating miR-323a-3p and miR-625-3p to classify hypertrophic cardiomyopathy in Friedreich\u2019s ataxia"],"prefix":"10.1038","volume":"16","author":[{"given":"Jos\u00e9 Santiago","family":"Ib\u00e1\u00f1ez-Cabellos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Baviera-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Alemany-Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Gonz\u00e1lez-Cabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Garc\u00eda-Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico V.","family":"Pallard\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Seco-Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"3","key":"50975_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/brain\/104.3.589","volume":"104","author":"AE Harding","year":"1981","unstructured":"Harding, A. E. Friedreich\u2019s ataxia: A clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104(3), 589\u2013620 (1981).","journal-title":"Brain"},{"issue":"Suppl 1","key":"50975_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","volume":"256","author":"M Pandolfo","year":"2009","unstructured":"Pandolfo, M. Friedreich ataxia: The clinical picture. J. Neurol. 256(Suppl 1), 3\u20138. https:\/\/doi.org\/10.1007\/s00415-009-1002-3 (2009).","journal-title":"J. Neurol."},{"issue":"23","key":"50975_CR3","first-page":"1391","volume":"124","author":"A Korner","year":"1983","unstructured":"Korner, A. & Barta, L. [Association of diabetes mellitus with Friedreich\u2019s ataxia]. Orv. Hetil. 124(23), 1391\u20132 (1983).","journal-title":"Orv. Hetil."},{"issue":"6","key":"50975_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/01241398-198411000-00003","volume":"4","author":"RB Cady","year":"1984","unstructured":"Cady, R. B. & Bobechko, W. P. Incidence, natural history, and treatment of scoliosis in Friedreich\u2019s ataxia. J. Pediatr. Orthop. 4(6), 673\u20136 (1984).","journal-title":"J. Pediatr. Orthop."},{"issue":"208","key":"50975_CR5","first-page":"489","volume":"52","author":"AE Harding","year":"1983","unstructured":"Harding, A. E. & Hewer, R. L. The heart disease of Friedreich\u2019s ataxia: A clinical and electrocardiographic study of 115 patients, with an analysis of serial electrocardiographic changes in 30 cases. Q. J. Med. 52(208), 489\u2013502 (1983).","journal-title":"Q. J. Med."},{"issue":"16","key":"50975_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","volume":"335","author":"A Durr","year":"1996","unstructured":"Durr, A. et al. Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia. N. Engl. J. Med. 335(16), 1169\u201375. https:\/\/doi.org\/10.1056\/NEJM199610173351601 (1996).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"50975_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2","volume":"87","author":"MB Delatycki","year":"1999","unstructured":"Delatycki, M. B. et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am. J. Med. Genet. 87 (2), 168\u2013174 (1999).","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"50975_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04996-9","volume":"7","author":"M Seco-Cervera","year":"2017","unstructured":"Seco-Cervera, M. et al. Circulating miR-323-3p is a biomarker for cardiomyopathy and an indicator of phenotypic variability in Friedreich\u2019s ataxia patients. Sci. Rep. 7(1), 5237. https:\/\/doi.org\/10.1038\/s41598-017-04996-9 (2017).","journal-title":"Sci. Rep."},{"issue":"5","key":"50975_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00109-023-02305-8","volume":"101","author":"X Ao","year":"2023","unstructured":"Ao, X. et al. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases. J. Mol. Med. (Berl) 101(5), 501\u201326. https:\/\/doi.org\/10.1007\/s00109-023-02305-8 (2023).","journal-title":"J. Mol. Med. (Berl)"},{"key":"50975_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032636","author":"JMT Hyttinen","year":"2023","unstructured":"Hyttinen, J. M. T., Blasiak, J. & Kaarniranta, K. Non-coding RNAs regulating mitochondrial functions and the oxidative stress response as putative targets against Age-Related Macular Degeneration (AMD). Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24032636 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"50975_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11886-023-02014-1","volume":"26","author":"CD Searles","year":"2024","unstructured":"Searles, C. D. MicroRNAs and cardiovascular disease risk. Curr. Cardiol. Rep. 26(2), 51\u201360. https:\/\/doi.org\/10.1007\/s11886-023-02014-1 (2024).","journal-title":"Curr. Cardiol. Rep."},{"key":"50975_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12050770","author":"G Gentile","year":"2022","unstructured":"Gentile, G. et al. Dysregulated miRNAs as biomarkers and therapeutical targets in Neurodegenerative Diseases. J. Pers. Med. https:\/\/doi.org\/10.3390\/jpm12050770 (2022).","journal-title":"J. Pers. Med."},{"issue":"6","key":"50975_CR13","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.gendis.2022.05.022","volume":"10","author":"A Dandare","year":"2023","unstructured":"Dandare, A., Khan, M. J., Naeem, A. & Liaquat, A. Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome. Genes Dis. 10(6), 2393\u2013413. https:\/\/doi.org\/10.1016\/j.gendis.2022.05.022 (2023).","journal-title":"Genes Dis."},{"issue":"1","key":"50975_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-024-01766-y","volume":"24","author":"TM Peluzzo","year":"2024","unstructured":"Peluzzo, T. M. et al. Plasma miRNAs correlate with structural brain and cardiac damage in Friedreich\u2019s ataxia. Cerebellum 24(1), 15. https:\/\/doi.org\/10.1007\/s12311-024-01766-y (2024).","journal-title":"Cerebellum"},{"issue":"1","key":"50975_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-0037-1607279","volume":"49","author":"S Dantham","year":"2018","unstructured":"Dantham, S., Srivastava, A. K., Gulati, S. & Rajeswari, M. R. Differentially regulated cell-free microRNAs in the plasma of Friedreich\u2019s ataxia patients and their association with disease pathology. Neuropediatrics 49(1), 35\u201343. https:\/\/doi.org\/10.1055\/s-0037-1607279 (2018).","journal-title":"Neuropediatrics"},{"issue":"1","key":"50975_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-024-00602-y","volume":"18","author":"C Vancheri","year":"2024","unstructured":"Vancheri, C. et al. An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease. Hum. Genomics 18(1), 50. https:\/\/doi.org\/10.1186\/s40246-024-00602-y (2024).","journal-title":"Hum. Genomics"},{"issue":"1","key":"50975_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054791","volume":"8","author":"S Bandiera","year":"2013","unstructured":"Bandiera, S. et al. Genetic variations creating microRNA target sites in the FXN 3\u2019-UTR affect frataxin expression in Friedreich ataxia. PLoS One 8(1), e54791. https:\/\/doi.org\/10.1371\/journal.pone.0054791 (2013).","journal-title":"PLoS One"},{"issue":"7\u20138","key":"50975_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/10408363.2017.1410520","volume":"54","author":"JL Garcia-Gimenez","year":"2017","unstructured":"Garcia-Gimenez, J. L. et al. Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory. Crit. Rev. Clin. Lab. Sci. 54(7\u20138), 529\u201350. https:\/\/doi.org\/10.1080\/10408363.2017.1410520 (2017).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"50975_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/B978-0-12-801899-6.00002-4","volume-title":"Epigenetic Biomarkers and Diagnostics","author":"L Peir\u00f3-Chova","year":"2016","unstructured":"Peir\u00f3-Chova, L. et al. The importance of biobanks in epigenetic studies A2. In Epigenetic Biomarkers and Diagnostics (eds Garc\u00eda-Gim\u00e9nez, J. et al.) 19\u201335 (Academic, 2016)."},{"issue":"12","key":"50975_CR20","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang, R. M. et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18(12), 1440\u201363. https:\/\/doi.org\/10.1016\/j.echo.2005.10.005 (2005).","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"12","key":"50975_CR21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","volume":"18","author":"M Galderisi","year":"2017","unstructured":"Galderisi, M. et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: An expert consensus document of the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging. 18(12), 1301\u201310. https:\/\/doi.org\/10.1093\/ehjci\/jex244 (2017).","journal-title":"Eur. Heart J. Cardiovasc. Imaging."},{"issue":"3","key":"50975_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/01.cir.75.3.565","volume":"75","author":"PN Casale","year":"1987","unstructured":"Casale, P. N., Devereux, R. B., Alonso, D. R., Campo, E. & Kligfield, P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: Validation with autopsy findings. Circulation 75(3), 565\u201372. https:\/\/doi.org\/10.1161\/01.cir.75.3.565 (1987).","journal-title":"Circulation"},{"issue":"4","key":"50975_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4), 402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"issue":"3","key":"50975_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.amjcard.2011.09.025","volume":"109","author":"SR Regner","year":"2012","unstructured":"Regner, S. R. et al. Analysis of echocardiograms in a large heterogeneous cohort of patients with Friedreich ataxia. Am. J. Cardiol. 109(3), 401\u20135. https:\/\/doi.org\/10.1016\/j.amjcard.2011.09.025 (2012).","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"50975_CR25","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/mds.22864","volume":"25","author":"B Rajagopalan","year":"2010","unstructured":"Rajagopalan, B. et al. Analysis of the factors influencing the cardiac phenotype in Friedreich\u2019s ataxia. Mov. Disord. 25(7), 846\u201352. https:\/\/doi.org\/10.1002\/mds.22864 (2010).","journal-title":"Mov. Disord."},{"issue":"6","key":"50975_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/ehjacc\/zuaa034","volume":"10","author":"M Biener","year":"2021","unstructured":"Biener, M. et al. Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction. Eur. Heart J. Acute Cardiovasc. Care. 10(6), 653\u201360. https:\/\/doi.org\/10.1093\/ehjacc\/zuaa034 (2021).","journal-title":"Eur. Heart J. Acute Cardiovasc. Care."},{"issue":"5","key":"50975_CR27","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s12311-022-01475-4","volume":"22","author":"C Pane","year":"2023","unstructured":"Pane, C. et al. The C-terminal cross-linked telopeptide of type I collagen (CTX-I) as a potential cardiomyopathy biomarker in friedreich ataxia patients. Cerebellum 22(5), 1034\u20131038. https:\/\/doi.org\/10.1007\/s12311-022-01475-4 (2023).","journal-title":"Cerebellum"},{"key":"50975_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.668324","volume":"12","author":"B Wang","year":"2021","unstructured":"Wang, B. et al. Comparison of the clinical value of miRNAs and conventional biomarkers in AMI: A systematic review. Front. Genet. 12, 668324. https:\/\/doi.org\/10.3389\/fgene.2021.668324 (2021).","journal-title":"Front. Genet."},{"issue":"6","key":"50975_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/eurheartj\/ehq013","volume":"31","author":"GK Wang","year":"2010","unstructured":"Wang, G. K. et al. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 31(6), 659\u201366. https:\/\/doi.org\/10.1093\/eurheartj\/ehq013 (2010).","journal-title":"Eur. Heart J."},{"issue":"Pt 12","key":"50975_CR30","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1242\/jcs.119966","volume":"126","author":"N Motohashi","year":"2013","unstructured":"Motohashi, N. et al. Regulation of IRS1\/Akt insulin signaling by microRNA-128a during myogenesis. J. Cell Sci. 126(Pt 12), 2678\u201391. https:\/\/doi.org\/10.1242\/jcs.119966 (2013).","journal-title":"J. Cell Sci."},{"issue":"1","key":"50975_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57838-6","volume":"10","author":"S Pfeiffer","year":"2020","unstructured":"Pfeiffer, S. et al. Circulating miR-330-3p in late pregnancy is associated with pregnancy outcomes among lean women with GDM. Sci. Rep. 10(1), 908. https:\/\/doi.org\/10.1038\/s41598-020-57838-6 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"50975_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191067","volume":"13","author":"L Akerman","year":"2018","unstructured":"Akerman, L., Casas, R., Ludvigsson, J., Tavira, B. & Skoglund, C. Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for Type 1 diabetes. PLoS One 13(1), e0191067. https:\/\/doi.org\/10.1371\/journal.pone.0191067 (2018).","journal-title":"PLoS One"},{"key":"50975_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molimm.2018.02.006","volume":"95","author":"J Sun","year":"2018","unstructured":"Sun, J. et al. miR-330-5p\/Tim-3 axis regulates macrophage M2 polarization and insulin resistance in diabetes mice. Mol. Immunol. 95, 107\u201313. https:\/\/doi.org\/10.1016\/j.molimm.2018.02.006 (2018).","journal-title":"Mol. Immunol."},{"issue":"6","key":"50975_CR34","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1159\/000495059","volume":"50","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. MicroRNA-323a-3p promotes pressure overload-induced cardiac fibrosis by targeting TIMP3. Cell. Physiol. Biochem. 50(6), 2176\u201387. https:\/\/doi.org\/10.1159\/000495059 (2018).","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"50975_CR35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1172\/JCI61498","volume":"122","author":"J Iwata","year":"2012","unstructured":"Iwata, J. et al. Modulation of noncanonical TGF-\u03b2 signaling prevents cleft palate in Tgfbr2 mutant mice. J. Clin. Invest. 122(3), 873\u201385. https:\/\/doi.org\/10.1172\/JCI61498 (2012).","journal-title":"J. Clin. Invest."},{"key":"50975_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109227","volume":"118","author":"ZH Liu","year":"2019","unstructured":"Liu, Z. H. et al. SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition. Biomed. Pharmacother. 118, 109227. https:\/\/doi.org\/10.1016\/j.biopha.2019.109227 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"50975_CR37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31756","author":"A Ramachandran","year":"2018","unstructured":"Ramachandran, A. et al. TGF-\u03b2 uses a novel mode of receptor activation to phosphorylate SMAD1\/5 and induce epithelial-to-mesenchymal transition. eLife https:\/\/doi.org\/10.7554\/eLife.31756 (2018).","journal-title":"eLife"},{"key":"50975_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184353","author":"S Donati","year":"2019","unstructured":"Donati, S., Ciuffi, S. & Brandi, M. L. Human circulating miRNAs real-time qRT-PCR-based analysis: An overview of endogenous reference genes used for data normalization. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20184353 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"50975_CR39","doi-asserted-by":"publisher","DOI":"10.20517\/2574-1209.2023.69","author":"S Maiocchi","year":"2023","unstructured":"Maiocchi, S. et al. Plasma microrna quantification protocol. Vessel Plus https:\/\/doi.org\/10.20517\/2574-1209.2023.69 (2023).","journal-title":"Vessel Plus"},{"issue":"9","key":"50975_CR40","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/mds.30302","volume":"40","author":"M Rossi","year":"2025","unstructured":"Rossi, M. et al. Unravelling the global tapestry of genetic ataxias: Epidemiology and genetic testing approaches. Mov. Disord. 40(9), 1805\u201320. https:\/\/doi.org\/10.1002\/mds.30302 (2025).","journal-title":"Mov. Disord."},{"issue":"3","key":"50975_CR41","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/ehf2.13238","volume":"8","author":"PJ Kennel","year":"2021","unstructured":"Kennel, P. J. et al. Longitudinal profiling of circulating miRNA during cardiac allograft rejection: A proof-of-concept study. ESC Heart Fail. 8(3), 1840\u20139. https:\/\/doi.org\/10.1002\/ehf2.13238 (2021).","journal-title":"ESC Heart Fail."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50975-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:11:33Z","timestamp":1778685093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50975-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50975"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50975-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experimental protocols and methods were carried out after obtaining approval from the Biomedical Research Ethics Committee of HCUV (2022\/173) and RVB (RVB21041ER) and it were conducted in accordance with the Declaration of Helsinki. All participants or their legal guardians provided written informed consent prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"JLG-G and FVP are co-founders and owns shares of EpiDisease S.L., a Spin-Off of the Consortium Center for Biomedical Network Research of the ISCIII. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15056"}}